Author

Azhar Orynbek

German Cancer Research Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Assay:ChIP-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:dimensionality reduction· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1

Frequent Co-Authors

Alina Ritter· 1 shared Ana BanitoiD· 1 shared Armin JaroschiD· 1 shared Benjamin Friedrich Berthold MayeriD· 1 shared C. Duong-NgoiD· 1 shared Clémence HenoniD· 1 shared Daniel BaumhoeriD· 1 shared David A. HorstiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alina Ritter

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Super-enhancer-driven CACNA2D2 is an EWSR1::WT1 signature gene encoding a diagnostic marker for desmoplastic small round cell tumor (DSRCT)

Florian H. Geyer, Alina Ritter, Seneca S. Kinn-Gurzo, Tobias Faehling, Jing Li, Armin Jarosch, C. Duong-Ngo, Endrit Vinca, Karim Aljakouch, Azhar Orynbek, Shunya Ohmura, T. Kirchner, Roland Imle, Laura Romero‐Pérez, Juan Díaz‐Martín, , Florencia Cidre‐Aranaz

The paper identifies CACNA2D2 as a super-enhancer-driven target of EWSR1::WT1 and demonstrates its utility as a diagnostic biomarker for DSRCT.

癌症：英文版 · Mar 15, 2025Peer-reviewedCancer Biology